Atrial fibrillation in older inpatients: are there any differences in clinical characteristics and pharmacological treatment between the frail and the non-frail?

被引:42
|
作者
Nguyen, T. N. [1 ,2 ,3 ,4 ]
Cumming, R. G. [4 ]
Hilmer, S. N. [1 ,2 ,3 ]
机构
[1] Univ Sydney, Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW 2006, Australia
[2] Univ Sydney, Royal N Shore Hosp, Dept Aged Care, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Sydney, NSW 2006, Australia
[4] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia
关键词
atrial fibrillation; frailty; anticoagulant; anti-arrhythmic; stroke; bleeding; ANTICOAGULATION THERAPY; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULATION; MAJOR HEMORRHAGE; HEART-FAILURE; HIGH-RISK; WARFARIN; STROKE; DIGOXIN; IMPACT;
D O I
10.1111/imj.12912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundFrailty is common in patients with atrial fibrillation and may impact on antithrombotic and anti-arrhythmic treatment. AimTo describe differences in clinical characteristics, prescription of antithrombotic and anti-arrhythmic medications and incidence of haemorrhage and stroke, between frail and non-frail older inpatients. MethodsProspective observational study in patients aged 65years with atrial fibrillation admitted to a teaching hospital in Sydney, Australia. Frailty was assessed using the Reported Edmonton Frail Scale, stroke risk with CHA2DS2-VASc score and bleeding risk with HAS-BLED score. Participants were followed after 6months for haemorrhages and strokes. ResultsWe recruited 302 patients (mean age 84.7 7.1years, 53.3% frail, 50% female, mean CHA2DS2-VASc 4.61 +/- 1.44, mean HAS-BLED 2.97 +/- 1.04). Frail participants were older and had more co-morbidities and higher risk of stroke but not haemorrhage. Upon discharge, 55.7% participants were prescribed with anticoagulants (49.3% frail, 62.6% non-frail, P = 0.02). Thirty-three per cent received antiplatelets only and 11.1% no antithrombotics, with no difference by frailty status. For anti-arrhythmics, 52.6% received rate-control drugs only, 11.8% rhythm-control drugs only and 13.5% both and 22.1% were not prescribed either, with no difference by frailty status. On univariate logistic regression, frailty decreased the likelihood of anticoagulant prescription (odds ratio (OR) 0.58, 95%CI 0.36-0.93), but this was not significant on multivariate analysis (OR 0.66, 95%CI 0.40-1.11). After 6months, overall incidence of ischaemic stroke was 2.1%, and in patients taking anticoagulants, incidence of major/severe bleeding was 6.3%, with no significant difference between frailty groups. ConclusionsFrailty status had little impact on antithrombotic prescription and no impact on anti-arrhythmic prescription.
引用
收藏
页码:86 / 95
页数:10
相关论文
共 47 条
  • [41] CLINICAL CHARACTERISTICS AND TREATMENT DIFFERENCES BETWEEN YOUNGER AND OLDER ONSET MICROSCOPIC COLITIS: A MULTICENTER RETROSPECTIVE COHORT STUDY
    Kamboj, Amrit K.
    Gujral, Amandeep
    Voth, Elida
    Penrice, Daniel
    McGoldrick, Jessica
    Pardi, Darrell S.
    Khalili, Hamed
    GASTROENTEROLOGY, 2020, 158 (06) : S1161 - S1161
  • [42] Age-Related Differences in the Clinical Characteristics and Treatment of Elderly Patients With Atrial Fibrillation in Japan - Insight From the ANAFIE (All Nippon AF In Elderly) Registry -
    Hiasa, Ken-ichi
    Kaku, Hidetaka
    Inoue, Hiroshi
    Yamashita, Takeshi
    Akao, Masaharu
    Atarashi, Hirotsugu
    Koretsune, Yukihiro
    Okumura, Ken
    Shimizu, Wataru
    Ikeda, Takanori
    Toyoda, Kazunori
    Hirayama, Atsushi
    Yasaka, Masahiro
    Yamaguchi, Takenori
    Teramukai, Satoshi
    Kimura, Tetsuya
    Kaburagi, Jumpei
    Takita, Atsushi
    Tsutsui, Hiroyuki
    CIRCULATION JOURNAL, 2020, 84 (03) : 388 - 396
  • [43] Substantial differences in initiation of antithrombotic treatment and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings: a nationwide cohort
    Mikkelsen, A. P.
    Hansen, M. L.
    Olesen, B.
    Hvidtfeldt, M. W.
    Husted, S.
    Johnsen, S. P.
    Brandes, A.
    Gislason, G.
    Torp-Pedersen, C.
    Lamberts, M.
    EUROPEAN HEART JOURNAL, 2013, 34 : 97 - 97
  • [44] Retrospective analysis of clinical characteristics and treatment differences between severe and non-severe neonatal types of pneumonia with RSV infection
    Lei, Chunxia
    Wan, Chunhui
    MEDICINE, 2025, 104 (02)
  • [45] Treatment Patterns and Clinical Characteristics Among Non-Valvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants: A Nationwide Population-Based Study in Korea
    Lee, Myung Y.
    Han, Sola
    Bang, Oh Y.
    On, Young K.
    Jang, Sung W.
    Han, Seongwook
    Won, Mi-Mi
    Park, Yoo J.
    Shin, Ji-Soo
    Kang, Seongsik
    Suh, Hae S.
    Kim, Young H.
    CIRCULATION, 2018, 138
  • [46] Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study
    Biteker, Murat
    Basaran, Ozcan
    Dogan, Volkan
    Altun, Ibrahim
    Karadeniz, Fatma Ozpamuk
    Tekkesin, Ahmet Ilker
    Cakilli, Yasin
    Turkkan, Ceyhan
    Hamidi, Mehmet
    Demir, Vahit
    Gursoy, Mustafa Ozan
    Ozturk, Muejgan Tek
    Aksan, Gokhan
    Seyis, Sabri
    Balli, Mehmet
    Alici, Mehmet Hayri
    Bozyel, Serdar
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 (08) : 1684 - 1690
  • [47] Risk Factors, Clinical Characteristics, and Treatment Differences Between Residents With and Without Nursing Home- and Non-Nursing Home-Acquired Clostridium difficile Infection
    Zarowitz, Barbara J.
    Allen, Carrie
    O'Shea, Terrence
    Strauss, Marcie E.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (07): : 585 - 595